NCT06557967

Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment

Prevalence of Brain Metastases and Impact on Survival in Metastatic Non-small Cell Lung Cancer by Line of Treatment

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 22,517 (actual)
• Sponsor: Daiichi Sankyo · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will use real-world data to assess prevalence of brain metastases in metastatic non-small cell lung cancer (mNSCLC) patients and its impact on associated clinical outcomes.

Detailed description

This retrospective cohort database study will generate real-world evidence describing prevalence of brain metastases at metastatic diagnosis and by line of therapy, patient characteristics, treatment patterns, and clinical outcomes in metastatic non-small cell lung cancer (mNSCLC) patients

Conditions

• Non-small Cell Lung Cancer
• Lung Cancer
• Metastatic Cancer
• Brain and Central Nervous System Cancer

Interventions

Type	Name	Description
OTHER	No drug	This is a non-interventional study and no study drug will be provided.

Timeline

• Start date: 2024-03-01
• Primary completion: 2024-06-28
• Completion: 2024-09-30
• First posted: 2024-08-16
• Last updated: 2024-12-09

Locations

1 site across 1 country: United States